That trial enrolled 338 adults with obesity or overweight without type 2 diabetes, randomized across placebo and four retatrutide dose levels (1 mg, 4 mg, 8 mg, 12 mg weekly), and followed participants for 24 weeks
This can help people with health problems that show up because of obesity
If you find Ozempic insufficient after an adequate trial, returning to tirzepatide through an affordable access pathway is a reasonable strategy
These are not guaranteed outcomes for every patient, but they are consistent with the broader health improvements typically associated with clinically significant weight loss
The fact that they slow down digestion also helps keep blood sugar levels from spiking throughout the day
In theory, transdermal delivery can be effective, but it depends on the substance